Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting

View ORCID ProfileLaith J Abu-Raddad, View ORCID ProfileHiam Chemaitelly, View ORCID ProfileJoel A Malek, Ayeda A Ahmed, Yasmin A Mohamoud, Shameem Younuskunju, View ORCID ProfileHoussein H. Ayoub, View ORCID ProfileZaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, View ORCID ProfileHanan F Abdul Rahim, Hadi M Yassine, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini
doi: https://doi.org/10.1101/2020.08.24.20179457
Laith J Abu-Raddad
1 Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laith J Abu-Raddad
  • For correspondence: lja2002@qatar-med.cornell.edu
Hiam Chemaitelly
1 Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hiam Chemaitelly
  • For correspondence: hsc2001@qatar-med.cornell.edu
Joel A Malek
2 Genomics Laboratory, Weill Cornell Medicine-Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joel A Malek
  • For correspondence: jom2042@qatar-med.cornell.edu
Ayeda A Ahmed
2 Genomics Laboratory, Weill Cornell Medicine-Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ays2003@qatar-med.cornell.edu
Yasmin A Mohamoud
2 Genomics Laboratory, Weill Cornell Medicine-Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yam2012@qatar-med.cornell.edu
Shameem Younuskunju
2 Genomics Laboratory, Weill Cornell Medicine-Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shy2016@qatar-med.cornell.edu
Houssein H. Ayoub
3 Department of Mathematics, Statistics, and Physics, Qatar University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Houssein H. Ayoub
  • For correspondence: hayoub@qu.edu.qa
Zaina Al Kanaani
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zaina Al Kanaani
  • For correspondence: zalkanaani@hamad.qa
Abdullatif Al Khal
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aalkhal@hamad.qa
Einas Al Kuwari
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ealkuwari@hamad.qa
Adeel A Butt
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aabutt@hamad.qa
Peter Coyle
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pcoyle@hamad.qa
Andrew Jeremijenko
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andrewjenko@hotmail.com
Anvar Hassan Kaleeckal
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: akaleeckal@hamad.qa
Ali Nizar Latif
4 Hamad Medical Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alatif2@hamad.qa
Riyazuddin Mohammad Shaik
5 Hamad Medical Corporation, Doha, Qatar;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rshaik@hamad.qa
Hanan F Abdul Rahim
6 College of Health Sciences, QU Health, Qatar University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hanan F Abdul Rahim
  • For correspondence: hanan.arahim@qu.edu.qa
Hadi M Yassine
7 Biomedical Research Center, Qatar University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hyassine@qu.edu.qa
Mohamed Ghaith Al Kuwari
8 Primary Health Care Corporation;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: malkuwari@phcc.gov.qa
Hamad Eid Al Romaihi
9 Ministry of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: halromaihi@moph.gov.qa
Sheikh Mohammad Al Thani
9 Ministry of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: malthani@moph.gov.qa
Roberto Bertollini
9 Ministry of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rbertollini@moph.gov.qa
  • Abstract
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background: Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is debated. We assessed risk and incidence rate of documented SARS-CoV-2 reinfection in a large cohort of laboratory-confirmed cases in Qatar. Methods: All SARS-CoV-2 laboratory-confirmed cases with at least one PCR positive swab that is ≥45 days after a first-positive swab were individually investigated for evidence of reinfection, and classified as showing strong, good, some, or weak/no evidence for reinfection. Viral genome sequencing of the paired first-positive and reinfection viral specimens was conducted to confirm reinfection. Risk and incidence rate of reinfection were estimated. Results: Out of 133,266 laboratory-confirmed SARS-CoV-2 cases, 243 persons (0.18%) had at least one subsequent positive swab ≥45 days after the first-positive swab. Of these, 54 cases (22.2%) had strong or good evidence for reinfection. Median time between first and reinfection swab was 64.5 days (range: 45-129). Twenty-three of the 54 cases (42.6%) were diagnosed at a health facility suggesting presence of symptoms, while 31 (57.4%) were identified incidentally through random testing campaigns/surveys or contact tracing. Only one person was hospitalized at time of reinfection, but still with mild infection. No deaths were recorded. Viral genome sequencing confirmed four out of 12 cases with available genetic evidence. Risk of reinfection was estimated at 0.01% (95% CI: 0.01-0.02%) and incidence rate of reinfection was estimated at 0.36 (95% CI: 0.28-0.47) per 10,000 person-weeks. Conclusions: SARS-CoV-2 reinfection can occur but is a rare phenomenon suggestive of a strong protective immunity against reinfection that lasts for at least a few months post primary infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors are grateful for support provided by the Ministry of Public Health, Hamad Medical Corporation, and the Biomedical Research Program, the Biostatistics, Epidemiology, and Biomathematics Research Core, and the Genomics Core at Weill Cornell Medicine-Qatar. The statements made herein are solely the responsibility of the authors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Studies were approved by Hamad Medical Corporation and Weill Cornell Medicine-Qatar Institutional Review Boards.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Relevant data are available within the manuscript and appendix.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted September 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Laith J Abu-Raddad, Hiam Chemaitelly, Joel A Malek, Ayeda A Ahmed, Yasmin A Mohamoud, Shameem Younuskunju, Houssein H. Ayoub, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul Rahim, Hadi M Yassine, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini
medRxiv 2020.08.24.20179457; doi: https://doi.org/10.1101/2020.08.24.20179457
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Laith J Abu-Raddad, Hiam Chemaitelly, Joel A Malek, Ayeda A Ahmed, Yasmin A Mohamoud, Shameem Younuskunju, Houssein H. Ayoub, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Adeel A Butt, Peter Coyle, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul Rahim, Hadi M Yassine, Mohamed Ghaith Al Kuwari, Hamad Eid Al Romaihi, Sheikh Mohammad Al Thani, Roberto Bertollini
medRxiv 2020.08.24.20179457; doi: https://doi.org/10.1101/2020.08.24.20179457

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (141)
  • Anesthesia (44)
  • Cardiovascular Medicine (408)
  • Dentistry and Oral Medicine (67)
  • Dermatology (47)
  • Emergency Medicine (141)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4805)
  • Forensic Medicine (3)
  • Gastroenterology (177)
  • Genetic and Genomic Medicine (670)
  • Geriatric Medicine (70)
  • Health Economics (187)
  • Health Informatics (621)
  • Health Policy (314)
  • Health Systems and Quality Improvement (200)
  • Hematology (84)
  • HIV/AIDS (155)
  • Infectious Diseases (except HIV/AIDS) (5278)
  • Intensive Care and Critical Care Medicine (323)
  • Medical Education (91)
  • Medical Ethics (24)
  • Nephrology (73)
  • Neurology (677)
  • Nursing (41)
  • Nutrition (110)
  • Obstetrics and Gynecology (124)
  • Occupational and Environmental Health (203)
  • Oncology (437)
  • Ophthalmology (138)
  • Orthopedics (36)
  • Otolaryngology (88)
  • Pain Medicine (35)
  • Palliative Medicine (15)
  • Pathology (127)
  • Pediatrics (193)
  • Pharmacology and Therapeutics (129)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (765)
  • Public and Global Health (1796)
  • Radiology and Imaging (321)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (68)
  • Sports Medicine (61)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (28)
  • Urology (37)